SNAP-8
SNAP-8 research peptide, labeled 10mg per vial. Batch B001 has Vanguard full-panel results: 97.10% chromatographic purity, 10.56mg measured quantity, identity, endotoxin, and sterility pass, and heavy metals non-detect. For laboratory research use only; not for human or animal use.
Review current and previous batch records, including COAs and supporting third-party testing documentation.
Browse Testing Archive →10mg · Batch B001 · Vanguard full panel
97.10% · HPLC-UV/VIS · Vanguard V260909-18 001
10.56 mg · HPLC-UV/VIS · Vanguard V260909-18 001
Pass · matches reference standard · HPLC-UV/VIS
Pass · below 5.00 EU/mg · LAL
Pass · no growth detected · USP <71>
As/Cd/Pb/Hg non-detect
MZ Biolabs: 99.21% purity; analysis 2026-09-18; HPLC-UV-MS quantitative report.
11.59 mg/vial measured quantity by HPLC-UV quantification.
Identity confirmed by HPLC-MS; expected monoisotopic mass 1074.49 Da; measured monoisotopic mass 1074.51 Da.
HPLC purity and measured quantity results.
HPLC-MS identity and mass confirmation.
MZ Biolabs: 99.07% purity; analysis 2026-10-03; HPLC-UV-MS quantitative report.
10.87 mg/vial measured quantity by HPLC-UV quantification.
Identity confirmed by HPLC-MS; expected monoisotopic mass 1074.49 Da; measured monoisotopic mass 1074.61 Da.
HPLC purity and measured quantity results.
HPLC-MS identity and mass confirmation.
Scope: Results apply to the tested sample and document analytical research-material testing only.